GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $454,000 | +2.5% | 10,440 | +2.7% | 0.13% | +19.1% |
| Q1 2022 | $443,000 | -10.9% | 10,165 | -9.8% | 0.11% | -5.2% |
| Q4 2021 | $497,000 | -10.3% | 11,265 | -22.3% | 0.12% | -18.3% |
| Q3 2021 | $554,000 | -72.1% | 14,505 | -70.9% | 0.14% | -72.0% |
| Q2 2021 | $1,988,000 | +12.9% | 49,930 | +1.2% | 0.51% | +2.6% |
| Q1 2021 | $1,761,000 | -45.1% | 49,330 | -43.4% | 0.50% | -48.5% |
| Q4 2020 | $3,205,000 | -8.0% | 87,095 | -5.8% | 0.96% | -13.8% |
| Q3 2020 | $3,482,000 | -3.8% | 92,500 | +4.2% | 1.12% | -10.5% |
| Q2 2020 | $3,621,000 | +8.2% | 88,770 | +0.5% | 1.25% | -5.2% |
| Q1 2020 | $3,346,000 | -22.6% | 88,320 | -4.0% | 1.32% | +3.5% |
| Q4 2019 | $4,324,000 | +11.6% | 92,022 | +1.4% | 1.27% | +3.0% |
| Q3 2019 | $3,873,000 | +7.3% | 90,747 | +0.6% | 1.23% | +7.0% |
| Q2 2019 | $3,610,000 | +3.5% | 90,197 | +8.1% | 1.15% | +1.1% |
| Q1 2019 | $3,487,000 | +16.6% | 83,437 | +6.6% | 1.14% | +4.0% |
| Q4 2018 | $2,990,000 | -0.8% | 78,245 | +4.2% | 1.10% | +7.6% |
| Q3 2018 | $3,015,000 | +8.1% | 75,065 | +8.5% | 1.02% | -20.5% |
| Q2 2018 | $2,789,000 | +222.8% | 69,185 | +212.8% | 1.28% | +252.2% |
| Q1 2018 | $864,000 | +10.9% | 22,115 | +0.7% | 0.36% | +10.3% |
| Q4 2017 | $779,000 | -17.0% | 21,955 | -5.0% | 0.33% | -21.6% |
| Q3 2017 | $938,000 | +0.1% | 23,115 | +6.4% | 0.42% | -4.1% |
| Q2 2017 | $937,000 | +3.0% | 21,720 | +0.6% | 0.44% | +10.9% |
| Q1 2017 | $910,000 | +9.5% | 21,580 | 0.0% | 0.40% | +5.3% |
| Q4 2016 | $831,000 | -23.1% | 21,580 | -13.8% | 0.38% | -28.8% |
| Q3 2016 | $1,080,000 | +5.6% | 25,030 | +6.0% | 0.53% | +4.3% |
| Q2 2016 | $1,023,000 | -2.3% | 23,605 | -4.1% | 0.51% | +1.4% |
| Q1 2016 | $1,047,000 | +5.4% | 24,605 | 0.0% | 0.50% | +11.4% |
| Q4 2015 | $993,000 | +2.1% | 24,605 | -2.8% | 0.45% | -3.2% |
| Q3 2015 | $973,000 | -8.0% | 25,305 | -0.4% | 0.46% | -2.9% |
| Q2 2015 | $1,058,000 | -13.5% | 25,395 | -4.2% | 0.48% | -11.0% |
| Q1 2015 | $1,223,000 | +2.3% | 26,495 | -5.4% | 0.54% | +5.3% |
| Q4 2014 | $1,196,000 | -58.9% | 27,995 | -55.8% | 0.51% | -58.9% |
| Q3 2014 | $2,912,000 | -33.4% | 63,335 | -22.5% | 1.24% | -26.8% |
| Q2 2014 | $4,370,000 | +0.1% | 81,712 | -0.0% | 1.69% | -10.0% |
| Q1 2014 | $4,366,000 | +4.9% | 81,724 | +4.8% | 1.88% | +8.1% |
| Q4 2013 | $4,164,000 | +6.4% | 77,986 | -0.0% | 1.74% | -1.2% |
| Q3 2013 | $3,914,000 | -1.1% | 78,016 | -1.4% | 1.76% | +3.2% |
| Q2 2013 | $3,956,000 | – | 79,159 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |